Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewJHU 37160 is a high affinity and highly potent activator of hM3Dq and hM4Di DREADDs (Ki values are 1.9 nM and 3.6 nM for hM3Dq and hM4Di in vitro, respectively; EC50 values are 0.2 nM and 18.5 nM for hM4Di and hM3Dq in vitro, respectively). Displays approximately 25-fold higher affinity for hM4Di compared to DREADD agonist 21 (Cat. No. 5548). Selectively displaces [3H]clozapine from DREADDs in vivo, but not from other clozapine binding sites. Inhibits locomotor activity in mice expressing hM3Dq and hM4Di in D1-expressing neurons, and increases hM3Dq-stimulated locomotion in rats expressing hM3Dq in TH-expressing neurons. Brain penetrant in mice, rats and non-human primates.
JHU 37160 is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.
M. Wt | 358.85 |
Formula | C19H20ClFN4 |
Storage | Store at RT |
Purity | ≥98% (HPLC) |
CAS Number | 2369979-68-8 |
PubChem ID | 139033723 |
InChI Key | SWSCWOSASZXIRK-UHFFFAOYSA-N |
Smiles | CCN1CCN(C2=NC3=CC(Cl)=CC=C3NC4=C(C=CC=C24)F)CC1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 17.94 | 50 |
The following data is based on the product molecular weight 358.85. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.5 mM | 5.57 mL | 27.87 mL | 55.73 mL |
2.5 mM | 1.11 mL | 5.57 mL | 11.15 mL |
5 mM | 0.56 mL | 2.79 mL | 5.57 mL |
25 mM | 0.11 mL | 0.56 mL | 1.11 mL |
References are publications that support the biological activity of the product.
Bonaventura et al (2019) High-potency ligands for DREADD imaging and activation in rodents and monkeys. Nat.Commun. 10 4627 PMID: 31604917
If you know of a relevant reference for JHU 37160, please let us know.
Keywords: JHU 37160, JHU 37160 supplier, JHU37160, DREADD, agonist, agonists, activator, activators, acutator, muscarinic, hM3Dq, hM4Di, brain, penetrant, DREADDs, 7198, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for JHU 37160. Do you know of a great paper that uses JHU 37160 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review JHU 37160 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Produced by Tocris, the chemogenetics research bulletin provides an introduction to chemogenetic methods to manipulate neuronal activity. It outlines the development of RASSLs, DREADDs and PSAMs, and the use of chemogenetic compounds. DREADD ligands and PSEMs available from Tocris are highlighted.
GPCRs can interact with multiple distinct transducers or regulatory proteins and these can be preferentially engaged in an agonist-specific manner giving rise to biased agonism. This poster discusses cutting edge GPCR signaling pharmacology and highlights therapeutic applications of biased agonism.